HMX2 and HIV-1 infection: However, oligomerization to structures larger than dimers seems to enhance the antiviral activity of hMX2, since interface I, III, and IV mutants often show weaker inhibition of HIV-1 infection compared to wild-type proteins [35,62,63,64,74].